Rhumbline Advisers boosted its position in Arteris, Inc. (NASDAQ:AIP - Free Report) by 79.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 76,974 shares of the company's stock after purchasing an additional 34,056 shares during the quarter. Rhumbline Advisers owned approximately 0.19% of Arteris worth $784,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. US Bancorp DE acquired a new stake in shares of Arteris in the 3rd quarter worth $34,000. R Squared Ltd purchased a new stake in Arteris in the fourth quarter valued at about $64,000. MetLife Investment Management LLC boosted its holdings in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock worth $131,000 after acquiring an additional 9,551 shares in the last quarter. Franklin Resources Inc. grew its stake in shares of Arteris by 0.8% during the third quarter. Franklin Resources Inc. now owns 1,491,415 shares of the company's stock worth $11,201,000 after acquiring an additional 12,375 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Arteris during the fourth quarter valued at about $134,000. 64.36% of the stock is owned by hedge funds and other institutional investors.
Arteris Stock Performance
Shares of Arteris stock traded down $0.47 on Monday, reaching $7.42. 257,014 shares of the stock were exchanged, compared to its average volume of 193,215. The business has a 50 day moving average price of $10.29 and a two-hundred day moving average price of $8.83. The firm has a market capitalization of $303.83 million, a price-to-earnings ratio of -8.53 and a beta of 1.21. Arteris, Inc. has a twelve month low of $5.76 and a twelve month high of $12.64. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.30.
Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.08). The business had revenue of $15.49 million for the quarter, compared to analyst estimates of $15.34 million. Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. Analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, CEO K Charles Janac sold 14,180 shares of the stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $10.01, for a total transaction of $141,941.80. Following the sale, the chief executive officer now directly owns 10,207,746 shares of the company's stock, valued at $102,179,537.46. This represents a 0.14 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Nicholas B. Hawkins sold 5,968 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $8.57, for a total value of $51,145.76. Following the sale, the chief financial officer now owns 186,123 shares in the company, valued at $1,595,074.11. This trade represents a 3.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 350,561 shares of company stock valued at $3,676,085 over the last ninety days. Company insiders own 33.70% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on AIP. Northland Securities lifted their target price on shares of Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 19th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $15.00 price target on shares of Arteris in a report on Tuesday, February 18th.
View Our Latest Report on AIP
About Arteris
(
Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Stories

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.